Cargando…

CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies

High-Grade Gliomas (HGG) are among the deadliest malignant tumors of central nervous system (CNS) in pediatrics. Despite aggressive multimodal treatment - including surgical resection, radiotherapy and chemotherapy - long-term prognosis of patients remains dismal with a 5-year survival rate less tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antonucci, Laura, Canciani, Gabriele, Mastronuzzi, Angela, Carai, Andrea, Del Baldo, Giada, Del Bufalo, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115105/ https://www.ncbi.nlm.nih.gov/pubmed/35603195 http://dx.doi.org/10.3389/fimmu.2022.867154

Ejemplares similares

The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors
por: Del Baldo, Giada, et al.
Publicado: (2023)

Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas
por: Ceglie, Giulia, et al.
Publicado: (2020)

Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy
por: Cipri, Selene, et al.
Publicado: (2023)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
por: Quintarelli, Concetta, et al.
Publicado: (2021)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
por: Arnone, Claudia Manuela, et al.
Publicado: (2021)

IMG-14. DEVELOPING A PREDICTIVE GRADING MODEL FOR CHILDREN WITH GLIOMAS BASED ON DIFFUSION KURTOSIS IMAGING METRICS: ACCURACY AND CLINICAL CORRELATIONS WITH SURVIVAL
por: Voicu, Ioan Paul, et al.
Publicado: (2020)

NFB-07. USE OF PEGYLATED INTERFERON α- 2b IN PEDIATRIC PATIENTS AFFECTED BY UNRESECTABLE PLEXIFORM NEUROFIBROMAS: MONOCENTRIC EXPERIENCE
por: Cacchione, Antonella, et al.
Publicado: (2020)

LGG-18. EVEROLIMUS TREATMENT IN PEDIATRIC PATIENTS AFFECTED BY LOW-GRADE GLIOMAS (pLGG) NON-TSC, BRAF v600-WT
por: Cacchione, Antonella, et al.
Publicado: (2020)

How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care
por: Cipri, Selene, et al.
Publicado: (2022)

Cerebellar mutism syndrome: From pathophysiology to rehabilitation
por: Fabozzi, Francesco, et al.
Publicado: (2022)

DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk
por: Caroleo, Anna Maria, et al.
Publicado: (2021)

Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience
por: Del Baldo, Giada, et al.
Publicado: (2022)

Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives
por: Ceglie, Giulia, et al.
Publicado: (2020)

Editorial: Pediatric Central Nervous System Tumors: State-of-the-Art and Debated Aspects
por: Carai, Andrea, et al.
Publicado: (2020)

Central Nervous System Metastasis in Neuroblastoma: From Three Decades Clinical Experience to New Considerations in the Immunotherapy Era
por: Mastronuzzi, Angela, et al.
Publicado: (2022)

Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience
por: Del Baldo, Giada, et al.
Publicado: (2022)

Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors
por: Vennarini, Sabina, et al.
Publicado: (2022)

Glioma Stem Cells in Pediatric High-Grade Gliomas: From Current Knowledge to Future Perspectives
por: Da-Veiga, Marc-Antoine, et al.
Publicado: (2022)

Delayed referral of pediatric brain tumors during COVID-19 pandemic
por: Carai, Andrea, et al.
Publicado: (2020)

Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
por: D’Alessandro, Annamaria, et al.
Publicado: (2021)

GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes
por: Bruzzese, Antonella, et al.
Publicado: (2020)

Full Sails against Cancer
por: Mastronuzzi, Angela, et al.
Publicado: (2022)

Multidisciplinary Management of Craniopharyngiomas in Children: A Single Center Experience
por: Del Baldo, Giada, et al.
Publicado: (2022)

HGG-19. IDENTIFICATION OF NOVEL SUBGROUP-SPECIFIC miRNA EXOSOMAL BIOMARKERS IN PEDIATRIC HIGH-GRADE GLIOMAS
por: Petrilli, Lucia Lisa, et al.
Publicado: (2020)

Secondary Narcolepsy as Worsening Sign in a Pediatric Case of Optic Pathway Glioma
por: Laus, Beatrice, et al.
Publicado: (2022)

Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
por: Gianno, Francesca, et al.
Publicado: (2022)

MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression
por: Catanzaro, Giuseppina, et al.
Publicado: (2022)

Low-Grade Gliomas in Patients with Noonan Syndrome: Case-Based Review of the Literature
por: Lodi, Mariachiara, et al.
Publicado: (2020)

The Prognostic Role of the C-Reactive Protein and Serum Lactate Dehydrogenase in a Pediatric Series of Bone Ewing Sarcoma
por: Del Baldo, Giada, et al.
Publicado: (2022)

Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
por: Del Baldo, Giada, et al.
Publicado: (2021)

SURG-03. IMMERSIVE VIRTUAL REALITY APPLICATIONS IN NEUROSURGICAL ONCOLOGY
por: Carai, Andrea, et al.
Publicado: (2020)

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
por: de Billy, Emmanuel, et al.
Publicado: (2021)

NSD1 Mutations and Pediatric High-Grade Gliomas: A Comparative Genomic Study in Primary and Recurrent Tumors
por: d’Amati, Antonio, et al.
Publicado: (2022)

Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
por: Pellegrino, Marsha, et al.
Publicado: (2020)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome
por: Petruzzellis, Giuseppe, et al.
Publicado: (2019)

Developing a Predictive Grading Model for Children with Gliomas Based on Diffusion Kurtosis Imaging Metrics: Accuracy and Clinical Correlations with Patient Survival
por: Voicu, Ioan Paul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tv2npg46b3enqj9tfd5mdnl97h